Abstract
Recently, we have read the original article written by Yaling Lu et al1 , which was published in European Journal of Neurology [1]. The authors enrolled 635 acute ischemic stroke patients with soluble suppression of tumorigenicity 2 (sST2) measurements from the China Antihypertensive Trial in Acute Ischemic Stroke, one multicenter randomized clinical trial in China, to explore the relationship between sST2 and post-stroke depression (PSD).
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
